系统白细胞导向的siRNA输送显示了环素D1作为一种抗炎性标
Dan Peer1, Eun Jeong Park, Yoshiyuki Morishita
1Immune Disease Institute and Department of Anesthesia, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115, USA.
概括
这项研究揭示了Cyclin D1 (CyD1) 作为一种潜在的抗炎性标. 在白细胞中抑制CyD1通过减少炎症和免疫细胞增殖来逆转实验性结肠炎.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
背景情况:
- 环素D1 (CyD1) 是一个关键的细胞循环调节剂和癌症标.
- 在炎症中,CyD1的调节升高,但其作用尚不清楚.
研究的目的:
- 研究CyD1在炎症中的作用.
- 开发一种针对白细胞中CyD1抑制的有针对性的方法.
主要方法:
- 开发了载有CyD1-小干扰RNA (siRNA) 的目标稳定纳米粒子 (tsNP).
- 使用β(7) 整合素抗体在体内向特定白细胞子集.
- 在实验诱导的大肠炎的小鼠中,系统地给出beta(7) I-tsNP.
主要成果:
- 在白细胞中使用向的 tsNP 成功静止 CyD1.
- 在小鼠中逆转实验性大肠炎.
- 已证明抑制白细胞增殖和T辅助细胞1细胞因子表达.
结论:
- 环素D1是一种可行的抗炎性标.
- 通过TSNP进行向siRNA传递是炎症性疾病的可行治疗策略.
相关概念视频
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...

